Team:Paris Bettencourt

From 2013.igem.org

(Difference between revisions)
Line 90: Line 90:
}
}
.cont p {
.cont p {
 +
  font-size:27px;
   line-height:28px;
   line-height:28px;
   width:auto;
   width:auto;
Line 187: Line 188:
   background:rgb(252,250,229);
   background:rgb(252,250,229);
}
}
 +
</style>
</style>
Line 206: Line 208:
     <div class="cont"><p style="font-size:32px;line-height:34px;">FIGHT TUBERCULOSIS WITH MODERN WEAPONS </p></div>
     <div class="cont"><p style="font-size:32px;line-height:34px;">FIGHT TUBERCULOSIS WITH MODERN WEAPONS </p></div>
     <div class="cont">
     <div class="cont">
-
       <p style="font-size:25px;">
+
       <p style="font-size:28px;">
-
       Tuberculosis (TB) is an infectious disease caused by <i>Mycobacterium tuberculosis</i> (Mtb) that affects nearly two billion people around the world. On this website we present four new ways to use the power of synthetic biology in the fight against TB; from TB detection, to drug targeting, to infiltrating macrophages, to sabotaging the synthesis of proteins.
+
       Tuberculosis (TB) is an infectious disease caused by <i>Mycobacterium tuberculosis</i> (Mtb) that affects nearly two billion people around the world. On this website we present four new ways to use the power of synthetic biology in the fight against TB.
       </p>
       </p>
     </div>
     </div>
     <div id="psdesc" class="spdesc">
     <div id="psdesc" class="spdesc">
       <div class="cont">
       <div class="cont">
-
<p style="font-size:25px;">A biosensor that detects the presence of sequence specific antibiotic resistance genes.</p>
+
<p style="font-size:28px;">A biosensor that detects the presence of sequence specific antibiotic resistance genes.</p>
       </div>
       </div>
     </div>
     </div>
     <div id="dsdesc" class="spdesc">
     <div id="dsdesc" class="spdesc">
       <div class="cont">
       <div class="cont">
-
<p style="font-size:25px;">A safe and specific high-throughput drug screening method that targets essential mycobacterial metabolic proteins.</p>
+
<p style="font-size:28px;">A safe and specific high-throughput drug screening method that targets essential mycobacterial metabolic proteins.</p>
       </div>    
       </div>    
     </div>
     </div>
     <div id="thdesc" class="spdesc">
     <div id="thdesc" class="spdesc">
       <div class="cont">
       <div class="cont">
-
<p style="font-size:25px;">A phage system with low fitness cost producing sRNA, which inhibit the synthesis of antibiotic resistance proteins.</p>
+
<p style="font-size:28px;">A phage system with low fitness cost producing sRNA, which inhibit the synthesis of antibiotic resistance proteins.</p>
       </div>
       </div>
     </div>
     </div>
     <div id="tcdesc" class="spdesc">
     <div id="tcdesc" class="spdesc">
       <div class="cont">
       <div class="cont">
-
<p style="font-size:25px;">Infiltrate macrophages with an <i>E.coli</i> producing TDMH, an enzyme that will lyse the Mycobacteria cell wall.</p>
+
<p style="font-size:28px;">Infiltrate macrophages with an <i>E.coli</i> producing TDMH, an enzyme that will lyse the Mycobacteria cell wall.</p>
       </div>
       </div>
 +
    </div>
     </div>
     </div>
   </div>
   </div>

Revision as of 03:34, 5 October 2013

Centre for Research and Interdisciplinarity (CRI)
Faculty of Medicine Cochin Port-Royal, South wing, 2nd floor
Paris Descartes University
24, rue du Faubourg Saint Jacques
75014 Paris, France
+33 1 44 41 25 22/25
team2013@igem-paris.org
Hit Counter by Digits
Copyright (c) 2013 igem.org. All rights reserved.